FocuSSced on the Target in Systemic Sclerosis-Interstitial Lung Disease Another Arrow in the Quiver?

被引：0
|
作者：
Matson, Scott M. [1 ]
Griffith, Melissa [2 ]
Lee, Joyce S. [2 ]
机构：
[1] Univ Kansas, Dept Med, Sch Med, Kansas City, KS 66160 USA
[2] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷 / 06期
关键词：
DOUBLE-BLIND; CYCLOPHOSPHAMIDE; PLACEBO;
D O I：
10.1164/rccm.202111-2587ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：608 / 610
页数：4
相关论文
共 50 条
  • [1] Rituximab for the treatment of systemic sclerosis-interstitial lung disease
    Hughes, Michael
    Denton, Christopher P.
    Khanna, Dinesh
    RHEUMATOLOGY, 2021, 60 (02) : 489 - 491
  • [2] Recent progress in systemic sclerosis-interstitial lung disease
    Castelino, Flavia V.
    Dellaripa, Paul F.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (06) : 570 - 575
  • [3] Molecular imaging for systemic sclerosis-interstitial lung disease
    Volkmann, Elizabeth R.
    LANCET RHEUMATOLOGY, 2021, 3 (03): : E163 - E164
  • [4] Enrichment Strategies for Systemic Sclerosis-Interstitial Lung Disease Trials
    Volkmann, Elizabeth R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209 (09) : 1067 - 1068
  • [5] Rituximab in Systemic Sclerosis-Interstitial Lung Disease, a Case Series of 18 Patients
    Guzelant, Gul
    Melikoglu, Melike
    Musellim, Benan
    Yilmaz, Deniz Demir
    Fresko, Izzet
    Seyahi, Emire
    Hatemi, Gulen
    Ugurlu, Serdal
    Hamuryudan, Vedat
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] TO ASSESS DIFFERENT PROGNOSIS INTERVALS FOR PATIENTS WITH SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE
    Ovsynnikova, Olga
    Koneva, Olga
    Garzanova, Liudmila
    Ananyeva, Lidia
    Starovoytova, Mayya
    Desinova, Oxana
    CHEST, 2021, 160 (04) : 1264A - 1264A
  • [7] RITUXIMAB IN SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE, A CASE SERIES OF 18 PATIENTS
    Guzelant, G.
    Melikoglu, M.
    Musellim, B.
    Yilmaz, D. D.
    Fresko, I.
    Seyahi, E.
    Hatemi, G.
    Ugurlu, S.
    Harnuryudan, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1274 - 1274
  • [8] Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis-Interstitial Lung Disease: A Systematic Review
    Landini, Nicholas
    Orlandi, Martina
    Bruni, Cosimo
    Carlesi, Edoardo
    Nardi, Cosimo
    Calistri, Linda
    Morana, Giovanni
    Tomassetti, Sara
    Colagrande, Stefano
    Matucci-Cerinic, Marco
    FRONTIERS IN MEDICINE, 2022, 8
  • [9] Expert Consensus on the Screening, Treatment, and Management of Patients with Systemic Sclerosis-Interstitial Lung Disease, and the Potential Role of Anti-Fibrotics in a Treatment Paradigm for Systemic Sclerosis-Interstitial Lung Disease: A Delphi Consensus Study
    Khanna, Dinesh
    Strek, Mary
    Southern, Brian
    Saggar, Rajan
    Hsu, Vivien
    Mayes, Maureen D.
    Silver, Rick
    Steen, Virginia D.
    Zoz, Donald
    Rahaghi, Franck
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] A Novel Prediction Tool for Progression of Systemic Sclerosis-Interstitial Lung Disease Despite Treatment with Immunosuppression
    Volkmann, Elizabeth
    Wilhalme, Holly
    Kim, Grace
    Goldin, Jonathan
    Assassi, Shervin
    Kuwana, Masataka
    Tashkin, Donald
    Roth, Michael
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2083 - 2085
12345